• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker CFO Jellison retires, Boehnlein steps up | Personnel Moves

Stryker CFO Jellison retires, Boehnlein steps up | Personnel Moves

January 27, 2016 By Fink Densford

MassDevice.com Personnel MovesStryker (NYSE:SYK) said yesterday that CFO and veep William Jellison is retiring, and will be replaced by former medsurg & neurotechnology group CFO Glenn Boehnlein.

The Kalamazoo, Mich.-based company said Jellison, who’s been with Styker for 3 years, will pursue positions on boards and devote more time to his family. Jellison will stay on through Q1 to aid in the transition.

“I want to thank Bill for his leadership since joining Stryker as he helped advance a series of key priorities, including implementing a layered hedging program, executing on a number of acquisitions, and facilitating the establishment of our European regional headquarters. These accomplishments have meaningfully contributed to our success and were achieved while enabling our internal talent pool to develop, including Glenn who has been promoted to CFO. I am confident in Glenn’s ability to lead our finance organization and partner with the broader organization to help Stryker continue to deliver sales growth at the high end of Med Tech while consistently achieving leveraged earnings gains,” CEO Kevin Lobo said in a press release.

Boehnlein joined Stryker in 2003 as endoscopy biz finance & IT veep, and was promoted through different roles, landing as MSNT group CFO in 2011. Prior to joining Stryker, Boehnlein spent 3 years as CFO of Success TV.

Yesterday, Stryker beat the consensus forecast on Wall Street with its 4th-quarter and full-year results, sales and earnings, sending share prices up today in late trading.

Stryker said it expects to put up adjusted EPS of $1.17 to $1.22 on sales growth of 5.0% to 6.0% during the 1st quarter. Full-year adjusted EPS are pegged at $5.50 to $5.70, again on sales growth of 5.0% to 6.0%.

SYK shares closed up 1.8% at $96.15 apiece yesterday.

 

 JenaValve lures BSX’s Van den Steen for chief commerical officer
JenaValve last week announced it lured ex-Boston Scientific (NYSE:BSX) peripheral intervention divisional commercial leader Pieter Van den Steen as its new chief commercial officer and GM of its Munich office.
Read more

 Ex-Hospira commercial chief Davies is Bonesupport’s new CEO
Bonesupport said it tapped ex-Hospira chief commercial officer as its new CEO, with current CEO Lloyd Diamond transitioning to chief business officer and relocating to the U.S. to manage business in the company’s largest market.
Read more

 SpineGuard taps ex-Medtronic, S&Ner McAdoo as biz dev veep
SpineGuard  (EPA:ALSGD) said Monday it picked up ex-Medtronic (NYSE:MDT), Smith & Nephew (NYSE:SNN) and Biomet (NYSE:ZBH) employee as its new veep of business development.
Read more

 Noxilizer Inc. names Theil senior veep and CFO
Sterilization and decontamination company Noxilizer said yesterday it named medical device and pharma vet David Theil as its senior veep and CFO.
Read more

Filed Under: Business/Financial News Tagged With: Biomet, Bonesupport, Boston Scientific, Hospira Inc., JenaValve, Medtronic, Noxilizer Inc, Personnel Moves, Smith & Nephew, SpineGuard, Stryker

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy